Depression Symptoms Treatment

Archive for the ‘Antidepressants’ Category

December 25th, 2010 by admin

Sertraline Hydrochlonde

Drug Approvals (British Approved Name Modified, US Adopted Name, rINN) International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish): Synonyms: CP-51974-01; CP-51974-1; Sertralina, hidrocloruro de BAN: Sertraline Hydrochloride [BANM] USAN: Sertraline Hydrochloride INN: Sertraline Hydrochloride [rINNM (en)] INN: Hidrocloruro de sertralina [rINNM (es)] INN: Sertraline, Chlorhydrate de [rINNM (fr)] INN: Sertralini Hydrochloridum [rINNM (la)] INN: Сертралина Гидрохлорид [rINNM (ru)] Chemical name: (1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthyl(methyl)amine hydrochloride Molecular formula: C17H17Cl2N,HCl =342.7 CAS: 79617-96-2 (sertraline); 79559-97-0 (sertraline hydrochloride) ATC code: N06AB06 Note. The following terms have been used as 'street names' or slang names for various forms of sertraline: Z's Zloft Zoomers. Pharmacopoeias. In Europe. European Pharmacopoeia, 6th ed. (Sertraline Hydrochlonde). A white or almost white, crystalline powder, ft exhibits polymorphism. Slightly soluble in water freely soluble in anhydrous alcohol Read more [...]
December 22nd, 2010 by admin

Reboxetine Mesilate

Drug Nomenclature Synonyms: FCE-20124 (reboxetine or reboxetine mesilate); PNU-155950E; Reboxetina, mesilato de; Reboxetine Mesylate BAN: Reboxetine Mesilate [BANM] USAN: Reboxetine Mesylate INN: Reboxetine Mesilate [rINNM (en)] INN: Mesilato de reboxetina [rINNM (es)] INN: Réboxétine, Mésilate de [rINNM (fr)] INN: Reboxetini Mesilas [rINNM (la)] INN: Ребоксетина Мезилат [rINNM (ru)] Chemical name: (±)-(2RS)-2-[(αRS)-α(2-Ethoxyphenoxy)benzyl]morpholine methanesulphonate Molecular formula: C19H23NO3,CH4O3S =409.5 CAS: 71620-89-8; 98769-81-4 (both reboxetine); 98769-82-5; 98769-84-7 (both reboxetine mesilate) ATC code: N06AX18 Adverse Effects Adverse effects most commonly seen with reboxetine include insomnia, dry mouth, constipation, and increased sweating. Disturbance of visual accommodation, loss of appetite, vertigo, tachycardia, palpitations, vasodilatation, orthostatic hypotension, urinary hesitancy or retention (mainly in men), and erectile dysfunction including ejaculatory delay are also reported as being common adverse reactions. There have been reports of allergic Read more [...]
December 19th, 2010 by admin

Protriptyline Hydrochloride

Drug Nomenclature Synonyms: MK-240; Protriptilina, hidrocloruro de BAN: Protriptyline Hydrochloride [BANM] USAN: Protriptyline Hydrochloride INN: Protriptyline Hydrochloride [rINNM (en)] INN: Hidrocloruro de protriptilina [rINNM (es)] INN: Protriptyline, Chlorhydrate de [rINNM (fr)] INN: Protriptylini Hydrochloridum [rINNM (la)] INN: Протриптилина Гидрохлорид [rINNM (ru)] Chemical name: 3-(5H-Dibenzo[a,d]cyclohept-5-enyl)propyl(methyl)amine hydrochloride Molecular formula: C19H21N,HCl =299.8 CAS: 438-60-8 (protriptyline); 1225-55-4 (protriptyline hydrochloride) ATC code: N06AA11 Read code: y025a Pharmacopoeias. In British and US. BP 2008 (Protriptyline Hydrochloride). A white to yellowish-white, odourless or almost odourless, powder. Freely soluble in water, in alcohol, and in chloroform practically insoluble in ether A 1% solution in water has a pH of 5.0 to 6.5. The United States Pharmacopeia 31, 2008 (Protriptyline Hydrochloride). A white to yellowish powder. Is odourless or has not more than a slight odour. Soluble 1 in 2 of water, 1 in 3.5 of alcohol, and Read more [...]
December 16th, 2010 by admin

Nortriptyline Hydrochloride

Drug Approvals (British Approved Name Modified, US Adopted Name, rINN) International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish): Synonyms: 38489; Nortriptilin-hidroklorid; Nortriptilina, hidrocloruro de; Nortriptilino hidrochloridas; Nortriptyliinihydrokloridi; Nortriptylin-hydrochlorid; Nortriptylinhydroklorid; Nortriptylini Hydrochloridum BAN: Nortriptyline Hydrochloride [BANM] USAN: Nortriptyline Hydrochloride INN: Nortriptyline Hydrochloride [rINNM (en)] INN: Hidrocloruro de nortriptilina [rINNM (es)] INN: Nortriptyline, Chlorhydrate de [rINNM (fr)] INN: Nortriptylini Hydrochloridum [rINNM (la)] INN: Нортриптилина Гидрохлорид [rINNM (ru)] Chemical name: 3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)propyl(methyl)amine hydrochloride Molecular formula: C19H21N,HCl =299.8 CAS: 72-69-5 (nortriptyline); 894-71-3 (nortriptyline hydrochloride) ATC code: N06AA10 Read code: y00VT [Enuresis] Pharmacopoeias. In Europe, Japan, and US. European Pharmacopoeia, 6th ed. (Nortriptyline Hydrochloride). A white or almost white powder. Sparingly Read more [...]
December 12th, 2010 by admin

Fluvoxamine Maleate

Drug Nomenclature Synonyms: DU-23000; Fluvoksamiinimaleaatti; Fluvoxamina, maleato de; Fluvoxamini Maleas; Fluvoxaminmaleat BAN: Fluvoxamine Maleate [BANM] USAN: Fluvoxamine Maleate INN: Fluvoxamine Maleate [rINNM (en)] INN: Maleato de fluvoxamina [rINNM (es)] INN: Fluvoxamine, Maléate de [rINNM (fr)] INN: Fluvoxamini Maleas [rINNM (la)] INN: Флувоксамина Малеат [rINNM (ru)] Chemical name: (E)-5-Methoxy-4´-trifluoromethylvalerophenone O-2-aminoethyloxime maleate Molecular formula: C15H21F3N2O2,C4H4O4 =434.4 CAS: 54739-18-3 (fluvoxamine); 61718-82-9 (fluvoxamine maleate) ATC code: N06AB08 Read code: y026Z Pharmacopoeias. In Europe and US. European Pharmacopoeia, 6th ed. (Fluvoxamine Maleate). A white or almost white, crystalline powder. Sparingly soluble in water freely soluble in alcohol and in methyl alcohol. The United States Pharmacopeia 31, 2008 (Fluvoxamine Maleate). A white to off-white, crystalline powder. Sparingly soluble in water freely soluble in alcohol and in chloroform practically insoluble in solvent ether. Protect from light. Adverse Effects, Treatment, and Read more [...]
December 9th, 2010 by admin

Paroxetine

Drug Approvals (British Approved Name, US Adopted Name, rINN) INNs in other languages (French, Latin, and Spanish): Synonyms: BRL-29060; FG-7051; Paroksetiini; Paroxetin; Paroxetinum BAN: Paroxetine USAN: Paroxetine INN: Paroxetine [rINN (en)] INN: Paroxetina [rINN (es)] INN: Paroxétine [rINN (fr)] INN: Paroxetinum [rINN (la)] INN: Пароксетин [rINN (ru)] Chemical name: (-)-trans-5-(4-p-Fluorophenyl-3-piperidylmethoxy)-1,3-benzodioxole Molecular formula: C19H20FNO3 =329.4 CAS: 61869-08-7 ATC code: N06AB05 Paroxetine Hydrochloride Drug Approvals (British Approved Name Modified, rINNM) International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish): Synonyms: BRL-29060A; Paroksetiinihydrokloridihemihydraatti; Paroksetino hidrochloridas hemihidratas; Paroxetin hydrochlorid; Paroxetina, hidrocloruro de; Paroxetine Hydrochloride Hemihydrate; Paroxetinhydrokloridhemihydrat; Paroxetini Hydrochloridum; Paroxetini Hydrochloridum Hemihydricum BAN: Paroxetine Hydrochloride [BANM] INN: Paroxetine Hydrochloride [rINNM (en)] INN: Hidrocloruro de paroxetina [rINNM (es)] INN: Read more [...]
December 8th, 2010 by admin

Trazodone Hydrochloride

Drug Approvals (British Approved Name Modified, US Adopted Name, rINN) International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish): Synonyms: AF-1161; Trazodona, hidrocloruro de BAN: Trazodone Hydrochloride [BANM] USAN: Trazodone Hydrochloride INN: Trazodone Hydrochloride [rINNM (en)] INN: Hidrocloruro de trazodona [rINNM (es)] INN: Trazodone, Chlorhydrate de [rINNM (fr)] INN: Trazodoni Hydrochloridum [rINNM (la)] INN: Тразодона Гидрохлорид [rINNM (ru)] Chemical name: 2-[3-(4-m-Chlorophenylpiperazin-1-yl)propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one hydrochloride Molecular formula: C19H22ClN5O,HCl =408.3 CAS: 19794-93-5 (trazodone); 25332-39-2 (trazodone hydrochloride) ATC code: N06AX05 Read code: y025f Note. The following terms have been used as 'street names' (see p.vi) or slang names for various forms of trazodone hydrochloride: Sleepeasy. Pharmacopoeias. In British and US. BP 2008 (Trazodone Hydrochloride). A white or almost white crystalline powder. Soluble in water sparingly soluble in alcohol practically insoluble in ether. A 1% solution Read more [...]
August 27th, 2010 by admin

Fluoxetine Hydrochlonde. Uses. Preparations

Uses and Administration Prevention of the reuptake of monoamine transmitters such as serotonin, which potentiates their action in the brain, appears to be associated with antidepressant activity. SSRIs such as fluoxetine preferentially inhibit the reuptake of serotonin compared with noradrenaline, and have limited direct action at other neurotrans-mitter sites, including muscarinic receptors. They therefore cause fewer antimuscarinic or sedative adverse effects than the tricyclic antidepressants and are less cardiotoxic. Citalopram is the most selective of the SSRIs currently available, whereas paroxetine is the most potent. SSRIs provide an alternative to the tricyclics for the treatment of depression. As with the tricyclics, it may be several weeks before an antidepressant effect is seen. Once depression has then resolved, maintenance therapy should be continued for at least 4 to 6 months (12 months in the elderly) to avoid relapse on stopping therapy. Patients with a history of recurrent depression should continue to receive maintenance treatment for at least 5 years and possibly indefinitely. Some Read more [...]
August 26th, 2010 by admin

Fluoxetine Hydrochlonde. Precautions. Interactions

Precautions Because of their epileptogenic effect SSRIs should be used with caution in patients with epilepsy or a history of such disorders (and should be avoided if the epilepsy is poorly controlled). Treatment should be stopped if seizures develop or when there is an increase in seizure frequency. Care is advised in patients receiving ECT as prolonged seizures have occurred rarely. SSRIs should also be used with caution in patients with cardiac disease or a history of bleeding disorders. Although SSRIs are preferred to tricyclics for the treatment of depression in patients with diabetes, they may alter glycaemic control and therefore caution is also warranted in diabetic subjects. SSRIs should be used with caution in patients with angle-closure glaucoma. Fluoxetine should be stopped in patients who develop a rash since systemic effects, possibly related to vasculitis, have occurred in such patients. Fluoxetine undergoes hepatic metabolism and should be used with caution and in reduced doses in patients with impaired hepatic function. Patients should be closely monitored during early therapy Read more [...]
August 25th, 2010 by admin

Fluoxetine Hydrochlonde. Adverse Effects

Drug Approvals (BANM, US Adopted Name, rINNM) International Nonproprietary Names (INNs) in main languages (French, Latin, Spanish): Synonyms: Fluoksetiinihydrokloridi; Fluoksetino hidrochloridas; Fluoxetin-hidroklorid; Fluoxetin-hydrochlorid; Fluoxetina, hidrocloruro de; Fluoxetinhydroklorid; Fluoxetini Hydrochloridum; LY-110140; Lilly-103472 BAN: Fluoxetine Hydrochloride [BANM] USAN: Fluoxetine Hydrochloride INN: Fluoxetine Hydrochloride [rINNM (en)] INN: Hidrocloruro de fluoxetina [rINNM (es)] INN: Fluoxétine, Chlorhydrate de [rINNM (fr)] INN: Fluoxetini Hydrochloridum [rINNM (la)] INN: Флуоксетина Гидрохлорид [rINNM (ru)] Chemical name: (±)-N-Methyl-3-phenyl-3-(α,α,α-trifluoro-p-tolyloxy)propylamine hydrochloride Molecular formula: C17H18F3NO,HCl =345.8 CAS: 54910-89-3 (fluoxetine); 59333-67-4 (fluoxetine hydrochloride) ATC code: N06AB03 Read code: y026e Note. The following terms have been used as 'street names' or slang names for various forms of fluoxetine: Distas; Green and whites; Greens; Limes; Pros; Zacs. Pharmacopoeias. In Europe and US. European Pharmacopoeia, Read more [...]